CODIAK BIOSCIENCES
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.
CODIAK BIOSCIENCES
Industry:
Biotechnology Medical Therapeutics
Founded:
2015-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.codiakbio.com
Total Employee:
101+
Status:
Active
Contact:
(617) 949-4100
Email Addresses:
[email protected]
Total Funding:
237.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Euro IPv6 PostalAddress Schema Unified Layer Comcast Akamai Hosted BlueHost
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amunix
Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.
Global Blood Therapeutics
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Post-IPO Equity - Codiak Biosciences
Yukon Partners
Yukon Partners investment in Series C - Codiak Biosciences
Qatar Investment Authority
Qatar Investment Authority investment in Series C - Codiak Biosciences
Alexandria Venture Investments
Alexandria Venture Investments investment in Series C - Codiak Biosciences
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Codiak Biosciences
EcoR1 Capital
EcoR1 Capital investment in Series C - Codiak Biosciences
Casdin Capital
Casdin Capital investment in Series C - Codiak Biosciences
Alaska Permanent Fund
Alaska Permanent Fund investment in Series C - Codiak Biosciences
Sirona Capital
Sirona Capital investment in Series C - Codiak Biosciences
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Codiak Biosciences
Key Employee Changes
Official Site Inspections
http://www.codiakbio.com Semrush global rank: 4.52 M Semrush visits lastest month: 2.35 K
- Host name: msp-a100-1135.arcusvps.net
- IP address: 162.247.143.135
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago